Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 4/20 | 0.78 |
| ▸ | TSHR | P16473 | 2/20 | 0.78 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.78 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.78 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.78 |
| ▸ | KDR | P35968 | 1/20 | 0.78 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.78 |
| ▸ | LMNA | P02545 | 2/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.64 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.64 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.64 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.64 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.64 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.64 |
| ▸ | RNASEL | Q05823 | 1/20 | 0.64 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.57 |
| ▸ | CA12 | O43570 | 2/20 | 0.57 |
| ▸ | CA1 | P00915 | 2/20 | 0.57 |
| ▸ | CA2 | P00918 | 2/20 | 0.57 |
| ▸ | CA7 | P43166 | 2/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5164197 | 0.94 | ALDH1A1 (0.66) | ESR1TSHRALDH1A1CHRM1SLC6A2 | |
| Butylparaben SCHEMBL2526213 | 0.91 | ESR1 (0.79) | ESR1TSHRALDH1A1CHRM1SLC6A2 | |
| SCHEMBL34633 | 0.90 | ADRB2 (0.64) | ESR1TSHRALDH1A1CHRM1SLC6A2 | |
| Propylparaben SCHEMBL10582852 | 0.89 | ESR1 (0.86) | ESR1TSHRALDH1A1CHRM1SLC6A2 | |
| SCHEMBL30830422 | 0.89 | ADRB2 (0.62) | ESR1TSHRALDH1A1CHRM1SLC6A2 | |
| SCHEMBL156746 | 0.89 | ADRB2 (0.62) | ESR1TSHRALDH1A1CHRM1SLC6A2 | |
| Propylparaben SCHEMBL977 | 0.88 | ESR1 (1.00) | ESR1TSHRALDH1A1CHRM1SLC6A2 | |
| Propylparaben SCHEMBL429594 | 0.88 | ESR1 (1.00) | ESR1TSHRALDH1A1CHRM1SLC6A2 | |
| Butylparaben SCHEMBL31213722 | 0.88 | ESR1 (0.66) | ESR1TSHRALDH1A1CHRM1SLC6A2 | |
| SCHEMBL11702741 | 0.88 | ALDH1A1 (0.59) | ESR1TSHRALDH1A1CHRM1SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9233066-B2 | Active formulations based on plant extracts; phytocosmetic and/or phytotherapeutic formulations comprising the same method for | Instituto Nacional de Pesquisa da Amazonia—INPA (BR) | 2016-01-12 | — | — | US | claimed |
| US-20100284943-A1 | Active Formulations Based on Plant Extracts; Phytocosmetic and/or Phytotherapeutic Formulations Comprising the Same Method For | FUNDACAO UNIVERSIDADE DO AMAZONAS - FUA - UFAM (BR) | 2010-11-11 | — | — | US | claimed |
| EP-2222271-A1 | ACTIVE FORMULATIONS BASED ON ESSENTIAL OIL OF PLANTS OF THE GENUS PROTIUM, GUATTERIA, CYPERUS AND THE MIXTURE THEREOF | Instituto Nacional De Pesquisa Da Amazônia - INPA (BR) | 2010-09-01 | — | — | EP | claimed |
| WO-2009082797-A1 | ACTIVE FORMULATIONS BASED ON ESSENTIAL OIL OF PLANTS OF THE GENUS PROTIUM, GUATTERIA, CYPERUS AND THE MIXTURE THEREOF | INSTITUTO NACIONAL DE PESQUISA DA AMAZÔNIA - INPA (BR) | 2009-07-09 | — | — | WO | claimed |
| EP-4025675-A1 | A PERFUME OIL MIXTURE | Symrise AG (DE) | 2022-07-13 | — | — | EP | disclosed |
| EP-3982910-A1 | A COOLING PREPARATION | Symrise AG (DE) | 2022-04-20 | — | — | EP | disclosed |
| EP-3911159-A1 | AN ANTIMICROBIAL MIXTURE | Symrise AG (DE) | 2021-11-24 | — | — | EP | disclosed |
| EP-3852713-A1 | COMPOSITIONS COMPRISING ODORLESS 1,2-PENTANEDIOL | Symrise AG (DE) | 2021-07-28 | — | — | EP | disclosed |
| WO-2020057761-A9 | COMPOSITIONS COMPRISING ODORLESS 1,2-PENTANEDIOL | SYMRISE AG (DE) | 2021-05-06 | — | — | WO | disclosed |
| WO-2021043585-A1 | A PERFUME OIL MIXTURE | SYMRISE AG (DE) | 2021-03-11 | — | — | WO | disclosed |
| WO-2020249216-A1 | A COOLING PREPARATION | SYMRISE AG (DE) | 2020-12-17 | — | — | WO | disclosed |
| WO-2020147953-A1 | AN ANTIMICROBIAL MIXTURE | SYMRISE AG (DE) | 2020-07-23 | — | — | WO | disclosed |
| WO-2020057761-A1 | COMPOSITIONS COMPRISING ODORLESS 1,2-PENTANEDIOL | SYMRISE AG (DE) | 2020-03-26 | — | — | WO | disclosed |
| EP-2328542-B1 | SUNSCREEN COMPOSITIONS COMPRISING COLOUR PIGMENS | BASF SE (DE) | 2018-04-25 | — | — | EP | disclosed |
| US-20170231889-A1 | Sunscreen Compositions Comprising Colour Pigments | BASF SE (DE) | 2017-08-17 | — | — | US | disclosed |
| EP-2710996-A2 | Sunscreen compositions comprising colour pigments | BASF SE (DE) | 2014-03-26 | — | — | EP | disclosed |
| US-7910119-B2 | Cosmetic emulsions with long-term stability | EVONIK GOLDSCHMIDT GMBH (DE) | 2011-03-22 | — | — | US | disclosed |
| US-20110033400-A1 | SUNSCREEN COMPOSITIONS COMPRISING COLOUR PIGMENTS | BASF SE (US) | 2011-02-10 | — | — | US | disclosed |
| US-20060204468-A1 | Cosmetic emulsions with long-term stability | GOLDSCHMIDT GMBH (DE) | 2006-09-14 | — | — | US | disclosed |
| WO-2005070386-A1 | BODY ART | THE DEZAC GROUP LIMITED (GB) | 2005-08-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110033400-A1 | SUNSCREEN COMPOSITIONS COMPRISING COLOUR PIGMENTS | TYR, ERCC1, ERCC4 | ESR1 1893/4885TSHR 4121/4885ALDH1A1 221/4885 |
| US-20170231889-A1 | Sunscreen Compositions Comprising Colour Pigments | TYR, ERCC1, ERCC4 | ESR1 1893/4885TSHR 4121/4885ALDH1A1 221/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.